Micah Greenwell, APRN
Family · Bardstown, KYNPI 1740692193
Payments from drug & device makers
Across 260 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$779
- Novo Nordisk$567
- Amgen$503
- Pfizer$381
- AstraZeneca$377
- Lilly USA, LLC$349
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,974100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $779 |
| Novo Nordisk | 41 | $567 |
| Amgen | 48 | $503 |
| Pfizer | 28 | $381 |
| AstraZeneca(2 entities) | 10 | $377 |
| Lilly USA, LLC | 23 | $349 |
| GSK | 23 | $336 |
| Boehringer Ingelheim | 7 | $112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Theratechnologies Inc. | 3 | $59 |
| Novartis | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Bayer | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Exact Sciences | 2 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,974 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 41 | $55,199 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 141 | $41,648 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $21,916 |
| FarxigaDapagliflozin Propanediol | 19 | $17,208 |
| EliquisApixaban | 19 | $16,631 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 66 | $13,751 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $12,061 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $10,920 |
| Repatha SureclickEvolocumab | 11 | $9,253 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $5,751 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 84 | $5,456 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $2,529 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 20 | $2,015 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 11 | $1,398 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 57 | $1,375 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKArexvy, Shingrix, Trelegy Ellipta | $336 | $66,319220 claims |
| Novo NordiskOzempic | $567 | $55,19941 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $377 | $39,12451 claims |
| PfizerEliquis | $381 | $16,63119 claims |
| AbbVieSynthroid | $779 | $94425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.
Other family in Bardstown
- Dale VincentBardstown$28K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.